BSAC Spring
Conference & AGM
15-16 May 2025, ICC Birmingham UK
Antimicrobial resistance is the greatest healthcare challenge of our time—be part of the solution. Join us at The International Convention Centre (ICC) in Birmingham on 15 & 16 May 2025 for the BSAC Spring Conference & AGM to explore cutting-edge research, connect with global experts, and help shape the future of our response to this global health emergency. This conference is RCPath CPD accredited (11 credits).
Register nowCutting-edge research and innovation
Stay up to date with the latest discoveries in antimicrobial resistance, emerging treatments, and cutting-edge research presented by leading experts. Whether you’re a clinician, researcher, or industry professional, attending this conference will give you exclusive access to the most current developments in the field.
Meet colleagues, peers, and experts
from around the world
This event provides a unique opportunity to meet and connect with colleagues, peers, and global thought leaders who are shaping the future of antimicrobial chemotherapy. Whether through structured sessions or informal networking opportunities, you’ll have the chance to share ideas and forge meaningful collaborations with like-minded professionals.
Experience the charm
of the UK’s second city
Join us in person in the vibrant and historic city of Birmingham, a hub of science and culture, and easily accessible from across the UK. The in-person experience offers not only invaluable face-to-face networking but also the chance to explore a dynamic city. If you can’t make it to Birmingham, don’t worry—there’s still the option to attend online, so you can engage with the conference from anywhere.
Programme
0845
0945
1415
1045
0345
Registration & coffee
0945
1045
1515
1145
0445
Welcome and opening remarks
Professor Andrew Seaton, NHS Greater Glasgow & Clyde and President, BSAC - View Bio
SESSION ONE - Vaccine preventable diseases: Advances in paediatric and adult vaccinations
Chair: Professor Andrew Seaton, NHS Greater Glasgow & Clyde and President, BSAC - View Bio
0955
1055
1525
1155
0455
Innovation in immunisation: valuing the life-course benefits of immunisation
Charlotte Vernhes, Vaccines Europe - View Bio
1015
1115
1545
1215
0515
Vaccine-preventable diseases in children across higher and lower middle income settings
Professor Susanna Esposito, University of Parma
1035
1135
1605
1235
0535
The role of vaccines to tackle AMR
Professor Angela Brueggemann, University of Oxford - View Bio
1055
1155
1625
1255
0555
Q&A
SESSION TWO - Invited lecture: In honour of the late Martin Skirrow
Chair: Dr Cliodna McNulty, University of Cardiff & retired medical microbiologist - View Bio
1115
1215
1645
1315
0615
Resolving the Campylobacter conundrum and Campylobacter control
Professor Brendan Wren, London School of Hygiene & Tropical Medicine - View Bio
1140
1240
1710
1340
0640
Q&A
1145
1245
1715
1345
0645
REFRESHMENT BREAK EXHIBITION & POSTER VIEWING
SESSION THREE - What's new in...
Chair: Professor Andrew Seaton, NHS Greater Glasgow & Clyde and President, BSAC - View Bio
1215
1315
1745
1415
0715
HAP diagnostics: HAP-FAST, a randomised clinical trial
Dr Dan Wootton, University of Liverpool - View Bio
1235
1335
1805
1435
0735
Management of endocarditis - the MDT approach and new ECS guidance
Professor Mark Dayer, The Mater Hospital, Dublin - View Bio
1255
1355
1825
1455
0755
Phage therapy approaches for chronic infections
Professor Mark Sutton, UKHSA
1315
1415
1845
1515
0815
Q&A
1330
1430
1900
1530
0830
LUNCH BREAK EXHIBITION & POSTER VIEWING
1335
1435
1905
1535
0835
BSAC AGM
SESSION FOUR
1415
1515
1945
1615
0915
Supported Session
SESSION FIVE - Invited papers: Antimicrobial stewardship
Chair: Dr David Jenkins, University Hospital Leicester & Immediate Past President, BSAC - View Bio
1500
1600
2030
1700
1000
Educating the public on Antimicrobial Resistance and Stewardship: Is there a need to re-direct UK public health campaigns?
Dr Christianne Micallef, Cambridgeshire & Peterborough Integrated Care System
1515
1615
2045
1715
1015
Implementation of a national training programme: barriers and facilitators to cascading Antimicrobial Stewardship training to primary care providers in England
Jade Meadows, UKHSA
1530
1630
2100
1730
1030
Enhancing Antimicrobial Stewardship Through the SMART-AMS Digital Model: A Strategic Framework to Tackle Antimicrobial Resistance
Dr Rasha Abdelsalam Elshenawy, University of Hertfordshire
SESSION SIX - Invited lecture
Chair: Dr Katy Stokes, University of Warwick - View Bio
1550
1650
2120
1750
1050
Tackling biocides to reduce resistance: a proposal for change
Natalie Bennett, Baroness Bennett of Manor Castle - View Bio
1615
1715
2145
1815
1115
Q&A
1625
1725
2155
1825
1125
REFRESHMENT BREAK EXHIBITION & POSTER VIEWING
SESSION SEVEN - Invited papers supported by JAC and JAC-AMR
Chair: Professor Carolyn Tarrant, University of Leicester and Associate Editor, JAC-AMR - View Bio
1655
1755
2225
1855
1155
Evaluating the application of Antimicrobial Stewardship in patients referred to the Sepsis Team
Dr Hibah Mirza, Walsall Manor Hospital
1710
1810
2240
1910
1210
Genomic evolution of methicillin-resistant Staphylococcus aureus (MRSA) ST149 associated with a health care worker leading to two outbreaks in a neonatal intensive care unit
Dr Iresha Asanthi, University Hospital North Midlands
1725
1825
2255
1925
1225
Antimicrobial pharmacist led penicillin allergy de-labelling (PADL) is safe and effective at removing low risk penA records
Daniel Hearsey & Neil Powell, Royal Cornwall Hospitals NHS Trust
1740
1840
2310
1940
1240
Differences in public knowledge and attitudes towards antimicrobial resistance and antibiotic use across the four UK nations
Dr Donna Lecky, UKHSA
1755
1855
2325
1955
1255
Q&A
1805
1905
2335
2005
1305
End of day 1 closing remarks
Professor Andrew Seaton, NHS Greater Glasgow & Clyde and President, BSAC - View Bio
0830
0930
1400
1030
0330
Registration & coffee
SESSION EIGHT - Antimicrobial Susceptibility Testing: What's new
Chair: Dr Annie Joseph, Nottingham University Hospitals NHS Trust - View Bio
0900
1000
1430
1100
0400
Paediatric dosing for 'I' category susceptibility
Dr Malte Kohns, University Children’s Hospital Basel
0920
1020
1450
1120
0420
Cefiderocol susceptibility testing: how, when and why
Dr Ioannis Baltas, University College London - View Bio
0940
1040
1510
1140
0440
Breakpoints for urinary tract infections
Professor Alasdair MacGowan, North Bristol NHS Trust - View Bio
1000
1100
1530
1200
0500
Q&A
SESSION NINE
1020
1120
1550
1220
0520
Supported Session
1050
1150
1620
1250
0550
REFRESHMENT BREAK EXHIBITION & POSTER VIEWING
SESSION TEN - The Delinkage Model
Chair: Dr Louise Sweeney, Manchester University NHS Foundation Trust - View Bio
1120
1220
1650
1320
0620
The UK's leadership role in developing new antibiotics and addressing AMR
1140
1240
1710
1340
0640
The delinkage model - from pilot to roll-out: where are we now?
Professor Philip Howard OBE, NHS England & NHS Improvement - North-East & Yorkshire - View Bio
1200
1300
1730
1400
0700
Supporting delinkage through prospective data collection - what is the UK Antimicrobial Registry telling us?
Professor Gareth Jones, University of Aberdeen - View Bio
1220
1320
1750
1420
0720
Q&A
SESSION ELEVEN
1235
1335
1805
1435
0735
Supported Session
1305
1405
1835
1505
0805
LUNCH BREAK EXHIBITION & POSTER VIEWING
SESSION TWELVE
1350
1450
1920
1550
0850
Supported session
SESSION THIRTEEN - Invited lectures
Chair: Professor Andrew Seaton, NHS Greater Glasgow & Clyde and President, BSAC - View Bio
1435
1535
2005
1635
0935
Faecal Microbiome Transplant - C-Diff
Dr Blair Merrick, Guy's and St Thomas' NHS Foundation Trust
1500
1600
2030
1700
1000
Fungal infections in the immunocompromised host
Dr Riina Rautemaa-Richardson, University of Manchester & Honorary Consultant Medical Mycologist, Manchester University NHS Foundation Trust - View Bio
1525
1625
2055
1725
1025
Q&A
SESSION FOURTEEN - Pharmacy First: Is it working? Views from the frontline
Chair: Professor Andrew Seaton, NHS Greater Glasgow & Clyde and President, BSAC - View Bio
1545
1645
2115
1745
1045
Panellists:
Stephen Riley, Deputy North West Regional Chief Pharmacist - Pharmacy Integration, NHS England North West Regional Team
Dr Kieran Hand, NHS England - View Bio
Lindsey Fairbrother, Community Pharmacist, Derbyshire. - View Bio
Tunde Sokoya, Community Pharmacist, Essex
Mark Koziol, Pharmacists' Defence Association - View Bio
1630
1730
2200
1830
1130
Closing remarks
Professor Andrew Seaton, NHS Greater Glasgow & Clyde and President, BSAC - View Bio
Registration
Registration is now open for either in person or virtual attendance, please register using the link below. For any questions regarding registration, please contact Esme Carruthers.
BSAC Members (NHS/not for profit)
Full Conference £160
One day £80
Non-members (NHS/not for profit)
Full conference £200
One day £100
Commercial
Full conference £400
One day £200
Student & LMIC concessions
Full conference £50
One day £25
Abstracts
Abstract submission
Submission is now closed
© 2025, British Society for Antimicrobial Chemotherapy. All Rights Reserved.
53 Regent Place, Birmingham B1 3NJ
Registered Charity 1093118